Posted - May 2020 in HSPRF News
3 first-class proposals receive funding
The Tom Wahlig Foundation in Germany that supports HSP research received 9 quality project proposals for funding in 2020.
Applications were assessed by a jury comprising Prof. Dr. Hübner, Jena; Dr. Christian Beetz, Rostock and Dr. Tom Wahlig, Münster, who agreed unanimously that 3 project proposals were particularly outstanding.
Announced in late February, the successful proposals are (in alphabetical order):
Coralie Fassier, Institut de la Vision, Paris France; Maria M. Magiera, Institut Curie, Orsay France
Boosting spastin microtubule-severing activity through TTLL-mediated tubulin polyglutamylation: a novel therapeutic strategy in SPG4-linked Hereditary Spastic Paraplegia
Dr. Ivana Ricca Molecular Medicine, IRCCS Pisa, Italy
Scouting biological effects of (the drug) Miglustat in subjects with Spastic Paraplegia type 11
OA Dr. Amir Jahić, Charité Universitätsmedizin Berlin Institute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Berlin Germany
In vivo and ex vivo characterization of a novel spastic paraplegia rescue knockout mouse model to define the therapeutic potential of somatic gene repair in HSP.
Read the full article (in German)
SOURCE: Tom Wahlig Foundation
3 winners of our funding projects 2020
February 19, 2020